Meningitis B Project Provides Survey
Meningococcal group B disease (also known as Meningitis B) is an uncommon but serious disease that is caused by a bacterial infection of the lining of the brain and spinal cord. The infection strikes and progresses quickly – sometimes without warning – and can be fatal, sometimes within 24 hours. Some survivors will have long-term physical and cognitive disabilities, including brain damage, hearing loss and loss of limbs. A vaccine for Meningitis B was developed in 2014, but is apparently not widely utilized.
The Meningitis B Project, a joint initiative of the Kimberly Coffey Foundation and the Emily Stillman Foundation, promotes the use of this vaccine and requests physicians and other health care providers to take a short survey about the utilization of this vaccine.